WaveMan
WaveMan · Company
TRV · Travelers Companies, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

TRV Travelers Companies (TRV) Insider Trading, Ownership & Congress Trades

Insurance · Fire, marine & casualty insurance · CIK 0000086312
Quote by TradingView
Congress · 1Form 144 · 7
Insider buyers, 180 days
0
Funds added, last quarter
884
13F, latest reported quarter
Conversions, 180 days
16
Codes C/M, not in net · $57.0M priced

What the filings say about TRV

Insiders, 180 days
-$91.9M net sold
12 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
1 bought · 0 sold
Latest: purchase, 2026-02-20
Planned sales (Form 144), 90 days
$66.2M
7 notices

Travelers Companies insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, TRAVELERS COMPANIES, INC. insiders sold a net $91.9M of stock across 308 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
Rowland David Donnay
EVP & Co-Chief Invest. Officer
SELL
2026-10-23 SECtraded 2026-10-22
5,000
$2.0M
n/a
Context
  • 8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Jul 22, 2026.
  • The trade is 47.7% of the 10,478 shares held after it.
  • 5 other insiders sold within 30 days.
  • 884 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP & Co-Chief Invest. Officer Rowland David Donnay sold about $2.0M of TRV on Oct 22, 2026; 5 other insiders sold within 30 days and 884 funds added in the latest 13F quarter.
Klenk Jeffrey P.
EVP & Pres., Bond & Spec. Ins.
SELL
2026-10-23 SECtraded 2026-10-22
9,016
$3.7M
n/a
Context
  • 9 earlier Form 4 trades (code P or S) here by this insider (9 sales), the last on Apr 20, 2026.
  • The trade is 148.4% of the 6,075 shares held after it.
  • 5 other insiders sold within 30 days.
  • 884 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP & Pres., Bond & Spec. Ins. Klenk Jeffrey P. sold about $3.7M of TRV on Oct 22, 2026; 5 other insiders sold within 30 days and 884 funds added in the latest 13F quarter.
Toczydlowski Gregory C
EVP & President, Business Ins.
SELL
2026-10-23 SECtraded 2026-10-22
32,671
$13.2M
n/a
Context
  • 6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Feb 20, 2026.
  • The trade is 159.2% of the 20,516 shares held after it.
  • 5 other insiders sold within 30 days.
  • 884 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP & President, Business Ins. Toczydlowski Gregory C sold about $13.2M of TRV on Oct 22, 2026; 5 other insiders sold within 30 days and 884 funds added in the latest 13F quarter.
Toczydlowski Gregory C
EVP & President, Business Ins.
SELL
2026-10-23 SECtraded 2026-10-22
2,100
$849.3K
n/a
Context
  • 6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Feb 20, 2026.
  • The trade is 11.4% of the 18,416 shares held after it.
  • 5 other insiders sold within 30 days.
  • 884 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP & President, Business Ins. Toczydlowski Gregory C sold about $849.3K of TRV on Oct 22, 2026; 5 other insiders sold within 30 days and 884 funds added in the latest 13F quarter.
OLIVO MARIA
EVP, ERM & Chief Risk Officer
SELL
2026-10-22 SECtraded 2026-10-21
15,100
$6.0M
+0.5%
Context
  • 13 earlier Form 4 trades (code P or S) here by this insider (13 sales), the last on Aug 28, 2026.
  • The trade is 14.6% of the 103,642 shares held after it.
  • 5 other insiders sold within 30 days.
  • 884 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, ERM & Chief Risk Officer OLIVO MARIA sold about $6.0M of TRV on Oct 21, 2026; 5 other insiders sold within 30 days and 884 funds added in the latest 13F quarter.
308 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 303 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$91.9M over 180 days
-$66.2M over 90 days
below 93% of Insurance
Congress
1 member bought in the last year
the lowest in Insurance
Funds
884 funds bought in last quarter
more than 96% of Insurance
Revenue
+5.2% year over year
below 64% of Insurance
Margin
12.9% net margin
more than 57% of Insurance
Buybacks
$4.6B repurchased, FY to 2026-09-30
the highest in Insurance
Short interest
2.9% of the float short (float per yahoo 2026-10-26) · 4.1 days to cover · settled 2026-09-30
more than 54% of Insurance
What changed in the last 30 days
Oct 23Chairman and CEO Schnitzer Alan D sold $35.3M (Oct 21)
Oct 23EVP & President, Business Ins. Toczydlowski Gregory C sold $14.0M (Oct 22)
Oct 22Officer Toczydlowski Gregory C filed to sell $14.0M by Oct 22 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Oct 21Officer Schnitzer Alan D filed to sell $35.3M by Oct 21 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Oct 21Officer OLIVO MARIA filed to sell $6.0M by Oct 21 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.

Watch TRV

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+50.8%12M
-0%+17%+35%+53%2025-102025-122026-022026-042026-062026-082026-10 2026-10-21 · Schnitzer Alan D sold $17.8M2026-10-22 · Toczydlowski Gregory C sold $13.2M2026-02-04 · Schnitzer Alan D sold $7.8M2025-11-06 · Frey Daniel S. sold $7.0M2026-02-04 · Schnitzer Alan D sold $6.8M2026-10-21 · Schnitzer Alan D sold $6.3M2026-10-21 · OLIVO MARIA sold $6.0M2026-10-21 · Schnitzer Alan D sold $5.1M2026-10-21 · Schnitzer Alan D sold $4.9M2026-01-23 · Klenk Jeffrey P. sold $4.7M2026-07-21 · Frey Daniel S. sold $4.1M2026-02-20 · Toczydlowski Gregory C sold $3.7M2026-10-22 · Klenk Jeffrey P. sold $3.7M2026-07-21 · Lefebvre Mojgan M sold $3.4M2026-02-26 · OLIVO MARIA sold $3.2M2026-02-06 · OLIVO MARIA sold $3.1M2026-02-06 · Klein Michael Frederick sold $3.0M2026-07-24 · Yin Daniel Tei-Hwa sold $2.8M2025-11-26 · OLIVO MARIA sold $2.6M2026-07-21 · Lefebvre Mojgan M sold $2.6M2026-10-20 · Klein Michael Frederick sold $2.4M2026-02-20 · Frey Daniel S. sold $2.4M2026-08-28 · OLIVO MARIA sold $2.2M2026-07-21 · Klein Michael Frederick sold $2.2M2026-04-28 · Kess Avrohom J. sold $2.1M2026-04-20 · Klein Michael Frederick sold $2.0M2026-10-22 · Rowland David Donnay sold $2.0M2026-04-20 · Klenk Jeffrey P. sold $2.0M2026-05-26 · Klein Michael Frederick sold $1.9M2026-07-22 · Rowland David Donnay sold $1.9M2025-10-28 · Klein Michael Frederick sold $1.8M2026-02-04 · Schnitzer Alan D sold $1.8M2026-02-19 · Lefebvre Mojgan M sold $1.7M2026-07-24 · Kurtzman Diane sold $1.6M2026-02-05 · HEYMAN WILLIAM H sold $1.5M2026-02-26 · Rowland David Donnay sold $1.5M2025-11-21 · Rowland David Donnay sold $1.5M2026-02-20 · Kess Avrohom J. sold $1.4M2025-11-24 · Kurtzman Diane sold $1.4M2026-05-22 · BESSETTE ANDY F sold $1.3M2026-02-17 · BESSETTE ANDY F sold $1.2M2026-10-21 · Schnitzer Alan D sold $1.2M2026-10-22 · Klenk Jeffrey P. filed to sell $3.7M2026-10-22 · Rowland David Donnay filed to sell $2.0M2026-10-22 · Toczydlowski Gregory C filed to sell $14.0M2026-10-21 · OLIVO MARIA filed to sell $6.0M2026-10-21 · Schnitzer Alan D filed to sell $35.3M2026-10-20 · Klein Michael Frederick filed to sell $2.9M2026-08-28 · OLIVO MARIA filed to sell $2.2M2026-07-28 · HEYMAN WILLIAM H filed to sell $932.9K2026-07-27 · HEYMAN WILLIAM H filed to sell $1.4M2026-07-24 · HEYMAN WILLIAM H filed to sell $2.0M2026-07-24 · Kurtzman Diane filed to sell $1.6M2026-07-24 · Yin Daniel Tei-Hwa filed to sell $2.8M2026-07-23 · THOMSEN LAURIE J filed to sell $527.6K2026-07-22 · BESSETTE ANDY F filed to sell $1.1M2026-07-22 · HEYMAN WILLIAM H filed to sell $1.7M2026-07-22 · Munson Paul E. filed to sell $564.1K2026-07-22 · Rowland David Donnay filed to sell $1.9M2026-07-21 · Frey Daniel S. filed to sell $5.2M2026-07-21 · HEYMAN WILLIAM H filed to sell $2.9M2026-07-21 · Klein Michael Frederick filed to sell $2.2M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns TRV: institutional holders (13F)

13F holdings, latest reported quarter
BlackRock, Inc.
20,949,680 sh
$6.9B
STATE STREET CORP
15,706,016 sh
$5.2B
VANGUARD CAPITAL MANAGEMENT LLC
13,886,981 sh
$4.6B
FMR LLC
10,272,794 sh
$3.4B
VANGUARD PORTFOLIO MANAGEMENT LLC
8,314,274 sh
$2.7B

Congress trades in TRV

STOCK Act disclosures, US House only, filed up to 45 days after the trade
Julia Letlow
Bought 2026-02-20 · disclosed 20 days later
$1,001 - $15,000
Valerie Hoyle
Sold 2025-09-23 · disclosed 17 days later
$1,001 - $15,000
Valerie Hoyle
Bought 2024-10-29 · disclosed 318 days later
$1,001 - $15,000
All stocks members of Congress are buying · Every member's trades

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

TRV planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
Klenk Jeffrey P.
Filed 2026-10-22
$3.7M
Rowland David Donnay
Filed 2026-10-22
$2.0M
Toczydlowski Gregory C
Filed 2026-10-22
$14.0M
OLIVO MARIA
Filed 2026-10-21
$6.0M
Schnitzer Alan D
Filed 2026-10-21
$35.3M

TRV mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Invesco KBW Property & Casualty Insurance ETF
$20.0M position · as of 2026-05-31
8.2%
iShares U.S. Insurance ETF
$31.6M position · as of 2026-06-30
7.5%
Select Insurance Portfolio
$30.6M position · as of 2026-05-31
5.3%
Global X Dow 30 Covered Call ETF
$7.9M position · as of 2026-07-31
4.3%
Financial Industries Fund
$10.7M position · as of 2026-07-31
3.8%
JNL/Mellon Dow Index Fund
$50.4M position · as of 2026-06-30
3.7%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
The Travelers Companies, Inc. Political Action Committee (T-Pac)
Cycle 2026 · $727K spent
$746.6K
Federal Election Commission, matched by the PAC's connected organisation
Executive pay vs shareholder return · Mr. Schnitzer
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$27.0M
$55.6M
$8.2M
+129%
+123%
2024
$23.1M
$61.2M
$7.2M
+87%
+95%
2023
$22.7M
$27.6M
$6.7M
+45%
+52%
2022
$21.1M
$50.4M
$6.3M
+40%
+39%
2021
$19.9M
$37.3M
$5.9M
+14%
+34%
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $91.9M sold by insiders over 180 days, 884 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $66.2M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
GSHDDGICAPLMRALHCCRVLHGTYKNSLAFLMKLOSCRGLTRUP

TRV financials

Revenue growth
+5.2%
XBRL, annual
Net margin
12.9%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$48.9B
four quarters, 2025-10-01 to 2026-09-30
Net margin, TTM
+17.0%
net income over revenue, 2025-10-01 to 2026-09-30
Free cash flow, TTM
n/a
capex not filed for the four quarters
Debt to equity
0.01x
current debt only, 2025-12-31 (9 months older than the period end); equity 2026-09-30
Cash flow to debt
35.59x
TTM operating cash flow over current debt only, 2025-12-31 (9 months older than the period end)
Return on equity
+27.5%
TTM net income over average of 2025-09-30 and 2026-09-30
Return on assets
+5.8%
TTM net income over average of 2025-09-30 and 2026-09-30
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
P/E, trailing
10.51x
close 2026-10-26 over four quarters of diluted EPS, 2025-10-01 to 2026-09-30
Enterprise value
n/a
no cash line filed
FCF yield
n/a
capex not filed for the four quarters
PEG, trailing
0.21x
P/E over trailing EPS growth of 50%: four quarters to 2026-09-30 against the four to 2025-09-30
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$48.8B$46.4B$41.4B$36.9B
Net income$6.3B$5.0B$3.0B$2.8B
EPS (diluted)27.4321.4712.7911.77
Operating cash flow$10.6B$9.1B$7.7B$6.5B
Buybacks$3.0B$1.0B$958.0M$2.0B
Dividends paid$979.0M$951.0M$908.0M$875.0M
SEC XBRL, fiscal years, as known on 2026-10-27

TRV Stock Sonar score 6/7 axes

Find similar shapesCompare

TRV ranks highest on financial health (96th percentile) and institutional and government (84th), and lowest on insider conviction (4th), among Insurance peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
80
Inputs
  • Return on equity+27.5% · 84 pct, sector of 116
  • Return on assets+5.8% · 75 pct, sector of 122
  • Return on invested capitalfewer than four consecutive quarters of operating income
  • Return on capital employedfewer than four consecutive quarters of operating income
Financial health
96
Inputs
  • Debt to equity0.01x · 93 pct, sector of 104
  • Cash flow to debt35.59x · 99 pct, sector of 97
Growth
36
Inputs
  • Revenue growth, YoY+5.2% · 36 pct, sector of 134
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
4
Inputs
  • Net Form 4 buying (codes P and S), 180d-$91.9M · 7 pct, sector of 100
  • Insider buyers, 180d0 · 0 pct, sector of 101
Institutional and government
84
Inputs
  • Funds adding, latest quarter884 · 96 pct, sector of 108
  • Congress net buyers, 365d1 · 73 pct, universe of 719
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
75
Inputs
  • Short interest, % of float+2.9% · 61 pct, sector of 138
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+4.4% · 88 pct, sector of 110
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

TRV filings, in plain words

Are Travelers Companies insiders buying or selling TRV?

In the 180 days to 2026-10-27, Travelers Companies insiders were net sellers, a net $91.9M across purchases and sales reported on Form 4, by 12 sellers.

Have members of Congress traded TRV?

Yes. In the year to 2026-10-27, 1 House member disclosed buying TRV and 0 House members disclosed selling it; the latest on record is a purchase by Julia Letlow dated 2026-02-20.

Are there planned insider sales of TRV?

Yes. 7 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $66.2M of stock; the latest, by Klenk Jeffrey P., was filed 2026-10-22.

Read the full summary

In the 180 days to 2026-10-27, Travelers Companies insiders were net sellers of TRV, a net $91.9M across purchases and sales reported on Form 4 by 12 sellers. None of the 29 insider sales was flagged as made under a Rule 10b5-1 plan. In the year to 2026-10-27, 1 member of Congress disclosed buying TRV and 0 members disclosed selling it; the latest on record is a purchase by Julia Letlow dated 2026-02-20. Insiders filed 7 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $66.2M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies